{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T23:54:23Z","timestamp":1784850863996,"version":"3.55.0"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"43","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Rationale:<\/jats:title>\n            <jats:p>Intestinal Beh\u00e7et's disease (BD) is characterized by intestinal ulcerations and gastrointestinal symptoms. Ulcerative intestinal tuberculosis (TB) is usually with dyspepsia, abdominal pain, vomiting, and weight loss. The 2 diseases exhibit similar clinical manifestations, but the most critical aspects of their clinical courses and required treatments are not at all similar.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patient concerns:<\/jats:title>\n            <jats:p>We present a case in which a patient with intestinal Beh\u00e7et's disease developed a de novo ulcerative intestinal TB infection after the start of anti-tumor necrosis factor-\u03b1 treatment. This was despite histopathologic examination without caseous necrosis granuloma and negative for acid-fast staining and latent TB screen.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Diagnoses:<\/jats:title>\n            <jats:p>Intestinal Beh\u00e7et's disease and intestinal TB.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Interventions:<\/jats:title>\n            <jats:p>The patient was treated with quadruple antituberculous chemotherapy, comprising rifapentine, isoniazid, ethambutol, and pyrazinamide.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Outcomes:<\/jats:title>\n            <jats:p>At follow-up about 3 months, the therapy of oral antituberculous drugs and thalidomide was continued and the patient's condition had stabilized.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Lessons:<\/jats:title>\n            <jats:p>This case illustrates the importance of closely monitoring patients who are on infliximab for possible onset of TB, even without abdominal symptoms, and with negative screening results for latent TB.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000017652","type":"journal-article","created":{"date-parts":[[2019,10,23]],"date-time":"2019-10-23T19:22:49Z","timestamp":1571858569000},"page":"e17652","source":"Crossref","is-referenced-by-count":8,"title":["Ulcerative intestinal tuberculosis case as a complication of treatment by infliximab for intestinal Beh\u00e7et's disease"],"prefix":"10.1097","volume":"98","author":[{"given":"Yan","family":"Shen","sequence":"first","affiliation":[{"name":"Rheumatology and Immunology Department"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai-fen","family":"Ma","sequence":"additional","affiliation":[{"name":"Rheumatology and Immunology Department"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-li","family":"Yang","sequence":"additional","affiliation":[{"name":"Medical Imaging Department, Huadong Hospital, Fudan University, Shanghai 200040, PR China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-long","family":"Guan","sequence":"additional","affiliation":[{"name":"Rheumatology and Immunology Department"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2019,10]]},"reference":[{"key":"R1-20240516","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0049-0172(98)80001-2","article-title":"Behcet's disease","volume":"27","author":"Kaklamani","year":"1998","journal-title":"Semin Arthritis Rheum"},{"key":"R2-20240516","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1056\/NEJM199910213411707","article-title":"Behcet's disease","volume":"341","author":"Sakane","year":"1999","journal-title":"N Engl J Med"},{"key":"R3-20240516","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1136\/ard.52.11.823","article-title":"Comparative study of the skin pathergy test with blunt and sharp needles in Behcet's disease: confirmed specificity but decreased sensitivity with sharp needles","volume":"52","author":"Dilsen","year":"1993","journal-title":"Ann Rheum Dis"},{"key":"R4-20240516","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1097\/00004836-200003000-00006","article-title":"Gastrointestinal manifestations of Behcet's disease","volume":"30","author":"Bayraktar","year":"2000","journal-title":"J Clin Gastroenterol"},{"key":"R5-20240516","doi-asserted-by":"crossref","first-page":"184","DOI":"10.3109\/s10165-010-0370-y","article-title":"Efficacy of combination therapy of anti-TNF-alpha antibody infliximab and methotrexate in refractory entero-Behcet's disease","volume":"21","author":"Iwata","year":"2011","journal-title":"Mod Rheumatol"},{"key":"R6-20240516","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.4049\/jimmunol.151.4.2273","article-title":"T cell epitope expression of mycobacterial and homologous human 65-kilodalton heat shock protein peptides in short term cell lines from patients with Behcet's disease","volume":"151","author":"Pervin","year":"1993","journal-title":"J Immunol"},{"key":"R7-20240516","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/0092-8674(89)90676-4","article-title":"The inducing role of tumor necrosis factor in the development of bactericidal granulomas during BCG infection","volume":"56","author":"Kindler","year":"1989","journal-title":"Cell"},{"key":"R8-20240516","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1136\/gut.49.5.725","article-title":"Treatment of intestinal Behcet's syndrome with chimeric tumour necrosis factor alpha antibody","volume":"49","author":"Travis","year":"2001","journal-title":"Gut"},{"key":"R9-20240516","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1002\/ibd.20457","article-title":"Efficacy of infliximab for induction and maintenance of remission in intestinal Behcet's disease","volume":"14","author":"Naganuma","year":"2008","journal-title":"Inflamm Bowel Dis"},{"key":"R10-20240516","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.2169\/internalmedicine.52.0589","article-title":"Efficacy of infliximab in patients with intestinal Behcet's disease refractory to conventional medication","volume":"52","author":"Kinoshita","year":"2013","journal-title":"Intern Med"},{"key":"R11-20240516","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s10620-016-4395-8","article-title":"Long-term outcomes and predictors of sustained response in patients with intestinal Behcet's disease treated with infliximab","volume":"62","author":"Zou","year":"2017","journal-title":"Dig Dis Sci"},{"key":"R12-20240516","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/j.jaci.2005.03.028","article-title":"Adverse reactions to biologic agents: focus on autoimmune disease therapies","volume":"116","author":"Lee","year":"2005","journal-title":"J Allergy Clin Immunol"},{"key":"R13-20240516","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.3899\/jrheum.081042","article-title":"Preventing tuberculosis flare in patients with inflammatory rheumatic diseases receiving tumor necrosis factor-alpha inhibitors in India -- An audit report","volume":"36","author":"Malaviya","year":"2009","journal-title":"J Rheumatol"},{"key":"R14-20240516","doi-asserted-by":"crossref","DOI":"10.1016\/j.rdc.2004.01.003","article-title":"Consideration of the risk and treatment of tuberculosis in patients who have rheumatoid arthritis and receive biologic treatments","volume":"30","author":"Bieber","year":"2004","journal-title":"Rheum Dis Clin North Am"},{"key":"R15-20240516","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1056\/NEJMoa011110","article-title":"Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent","volume":"345","author":"Keane","year":"2001","journal-title":"N Engl J Med"},{"key":"R16-20240516","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/00054725-200108000-00010","article-title":"Colonoscopic findings in intestinal Behcet's disease","volume":"7","author":"Lee","year":"2001","journal-title":"Inflamm Bowel Dis"},{"key":"R17-20240516","first-page":"169","article-title":"Clinicopathological profile of patients with abdominal tuberculosis","volume":"9","author":"Miah","year":"2011","journal-title":"J Nepal Health Res Counc"},{"key":"R18-20240516","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1016\/j.gie.2007.12.048","article-title":"Intestinal tuberculosis in a patient on infliximab treatment","volume":"67","author":"Karagiannis","year":"2008","journal-title":"Gastrointest Endosc"},{"key":"R19-20240516","doi-asserted-by":"crossref","first-page":"4237","DOI":"10.3748\/wjg.v16.i33.4237","article-title":"Multi-site abdominal tuberculosis mimics malignancy on 18F-FDG PET\/CT: report of three cases","volume":"16","author":"Tian","year":"2010","journal-title":"World J Gastroenterol"},{"key":"R20-20240516","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1159\/000363066","article-title":"Differential diagnosis of Crohn's disease and intestinal tuberculosis in patients with spontaneous small-bowel perforation","volume":"31","author":"Kim","year":"2014","journal-title":"Dig Surg"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000017652","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,16]],"date-time":"2024-05-16T22:08:38Z","timestamp":1715897318000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000017652"}},"subtitle":["A case report"],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":20,"journal-issue":{"issue":"43","published-online":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000017652","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10]]}}}